Terms: = Bone cancer AND EML4, ENSG00000143924, 27436 AND Prognosis
2 results:
1. Transformation of NSCLC to SCLC harboring eml4-ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
Lingling X; Maoxi C; Wei Y; Jieting Z; Yuanyuan Y; Ning X
Lung Cancer; 2023 Dec; 186():107415. PubMed ID: 37907052
[TBL] [Abstract] [Full Text] [Related]
2. Lung cancer and pregnancy.
Sarıman N; Levent E; Yener NA; Orki A; Saygı A
Lung Cancer; 2013 Mar; 79(3):321-3. PubMed ID: 23254266
[TBL] [Abstract] [Full Text] [Related]
